Search

Akash Jain

from Cincinnati, OH
Get Report
Connected to:
Aashish Jain, 36Abhi Jain, 28Achint Jain, 41Advait Jain, 39Ajay K Jain, 56Akash Jain, 49Akinchan Jain, 47Akshat K Jain, 53Akshi Jain, 33Alekh Jain, 41

Akash Jain Phones & Addresses

  • Cincinnati, OH
  • Pittsburgh, PA
  • Erie, PA
  • East Windsor, NJ
  • Plainsboro, NJ
  • 1341 Beechwood Blvd APT 2, Pittsburgh, PA 15217 (412) 512-2299

Work

Company: XYZ Address: Abc

Education

Degree: High school graduate or higher

Emails

a***[email protected]

Specialities

Buyer's Agent • Listing Agent

Professional Records

Real Estate Brokers

Akash Jain Photo 1

Akash Jain, Pune IN

View page
Specialties:
Buyer's Agent
Listing Agent
Work:
XYZ
Abc
 (Office)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Akash Jain
General Manager
Jain and Jain LLC
Nonresidential Building Operator Dwelling Operator
55 Washington St, East Orange, NJ 07017
PO Box 185, Holmdel Village, NJ 07733
(973) 677-0499

Publications

Us Patents

Compounds For The Treatment Of Conditions Associated With Dgat1 Activity

View page
US Patent:
20150166522, Jun 18, 2015
Filed:
Feb 24, 2015
Appl. No.:
14/630624
Inventors:
Marilyn DELACRUZ - Matawan NJ, US
Baoqing GONG - Morris Plains NJ, US
Akash JAIN - Burlington MA, US
Yansong LU - Edison NJ, US
Lijun ZHANG - Shanghai, CN
Assignee:
NOVARTIS AG - Basel
International Classification:
C07D 413/12
A61K 31/4439
Abstract:
The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.

Compounds For The Treatment Of Conditions Associated With Dgat1 Activity

View page
US Patent:
20140200246, Jul 17, 2014
Filed:
Jan 10, 2014
Appl. No.:
14/152282
Inventors:
Marilyn DELACRUZ - Matawan NJ, US
Baoqing GONG - Morris Plains NJ, US
Akash JAIN - Burlington MA, US
Yansong LU - Edison NJ, US
Lijun ZHANG - Shanghai, CN
Assignee:
NOVARTIS AG - Basel
International Classification:
C07D 413/12
A61K 45/06
A61K 31/4439
US Classification:
514338, 5462717
Abstract:
The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.
Control profile
Akash Jain from Cincinnati, OH Get Report